LysRs-IN-1
CAS No. 281676-77-5
LysRs-IN-1( 9-carboxymethylguanine )
Catalog No. M26286 CAS No. 281676-77-5
LysRs-IN-1 is a Lysyl-tRNA synthetase (LysRs) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 223 | In Stock |
|
| 100MG | 319 | In Stock |
|
| 200MG | 437 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLysRs-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionLysRs-IN-1 is a Lysyl-tRNA synthetase (LysRs) inhibitor.
-
DescriptionLysRs-IN-1 is a Lysyl-tRNA synthetase (LysRs) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms9-carboxymethylguanine
-
PathwayOthers
-
TargetOther Targets
-
RecptorMT1 receptor| MT2 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number281676-77-5
-
Formula Weight209.165
-
Molecular FormulaC7H7N5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (398.40 mM)
-
SMILESNc1nc2n(CC(O)=O)cnc2c(=O)[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cltrinin
Citrinin (NSC 186) is a mycotoxin that causes food contamination and has different toxic effects. Citrinin is an effective oral anticancer agent. Citrinin has various regulatory effects on mouse immune system, including regulating the number of immune cells, inducing apoptosis and autophagy of immune cells, altering toll-like receptor expression and cytokine production. Citrinin can induce oxidative stress and lead to early apoptosis of oocytes. Low doses of Citrinin have neuroprotective effects against glutamate-induced excitotoxicity in rat cortical neurons. In addition, Citrinin also has antibacterial activity.
-
PA-8
PA-8 is a small molecule receptor antagonist for PACAP Type I (PAC1) that is selective, effective, and orally active. PA-8 inhibits PacAP-induced CREB phosphorylation at PAC1- receptors, but does not inhibit VPAC1- or vpac2 receptors.
-
DPDPE
Prototypical selective δ-opioid receptor agonist peptide. Inhibits electrically stimulated contraction of mouse vas deferens in vitro (EC50 = 5.2 nM), and is antinociceptive in vivo.
Cart
sales@molnova.com